P
Phathom Pharmaceuticals D
D
PHAT
13.070
USD
-0.39
(-2.90%)
مفتوح الان
حجم التداول
30,167
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
1,038,151,629
العنوان: Phathom Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.